Evolve Financial
Portfolio Teardown · No. 04 · July 2026
Corporate 13F Portfolio · Fiscal Q1 2026 Cutoff · Filed May 15, 2026

NVIDIA is quietly building the world's most concentrated AI-infrastructure equity book.

$18.4B across seven public names — plus a shadow book of private & structured stakes that dwarfs the 13F.

NVIDIA Corp (CIK 0001045810) files Form 13F-HR as an institutional manager because its treasury holds >$100M of Section 13(f) equity securities — a status it's held for years but which only became newsworthy after CoreWeave's March 2025 IPO. As of the latest filing (period ending March 31, 2026), the reported portfolio spans seven positions worth $18.37B, up +40.2% QoQ and +1,502% YoY. What's not in the 13F is arguably bigger: NVIDIA's non-marketable equity book ballooned from $3.4B to $22.3B during FY2026 alone, and by April 2026 carried $5.3B of cumulative unrealized gains. Structured deals in Nebius, Marvell, and Lumentum — plus commitments to OpenAI, xAI, and Groq — sit off the 13F entirely and are covered in the callout below.

13F Portfolio Value
$18.37B
7 positions · as of 3/31/26
↑ +$5.27B QoQ
Quarter-over-Quarter Δ
+40.2%
from $13.10B (Q4 '25)
2 new · 1 add
Non-Marketable Equity MV
$22.25B
Note 8, 10-K FY26 · private + illiquid
+$18.9B YoY
Largest Single Stake
$9.48B
Intel Corp · 51.6% of 13F book
214.8M shares
Section 01 · Full Position Table

Every public position, 5 quarters, side-by-side.

Values in $ millions ($M) at quarter-end market value. Column totals equal SEC-reported 13F aggregate. "—" = pre-hold, "$0" = post-exit.

Company Tkr Sector Q-4 · 3/31/25 Q-3 · 6/30/25 Q-2 · 9/30/25 Q-1 · 12/31/25 Q0 · 3/31/26 Move
Intel Corp INTC Semiconductors $7,925 $9,482 Hold
CoreWeave Inc CRWV AI cloud infra $897 $3,943 $3,323 $1,739 $3,657 Added
Synopsys Inc SNPS EDA / chip design $2,190 $1,911 Hold
Coherent Corp COHR Optical networking $1,911 New
Nokia Oyj NOK Telecom / RAN $1,076 $1,341 Hold
Nebius Group NV NBIS AI cloud infra (EU) $28 $52 $101 $175 $124 Hold
Generate Biomedicines GENB AI drug discovery $10 New
Arm Holdings plc ARM Semi IP / CPU arch $121 $173 $192 $0 Exited
Applied Digital Corp APLD Neocloud / data ctrs $43 $85 $177 $0 Exited
Recursion Pharmaceuticals RXRX AI biotech $34 $62 $37 $0 Exited
WeRide Inc WRD Autonomous driving (CN) $16 $18 $17 $0 Exited
SEC-reported 13F total $1,147 $4,333 $3,844 $13,105 $18,374

Reconciliation note. Row sums tie to SEC-reported quarterly aggregates within ±0.5% (rounding on percentage-derived component values for smaller positions). Position values for Intel, CoreWeave, Synopsys, Coherent, and Nokia are anchored to the primary 13F filings and cross-referenced against Nvidia's announced acquisition prices (INTC @ $23.28, SNPS @ $414.79, COHR unnamed, NOK @ ~$6.20). Smaller positions (NBIS, APLD, RXRX, WRD, ARM) are triangulated from disclosed share counts × quarter-end market prices. No 13F-HR/A amendments have been filed by NVIDIA for any of the five periods shown — meaning no confidential-treatment positions have been unmasked; the reported book is complete as filed. See accession numbers: 0001045810-25-000102 (Q1'25), -25-000199 (Q2'25), -25-000219 (Q3'25), -26-000011 (Q4'25), -26-000042 (Q1'26).

Section 02 · Top Holdings, Ranked

Six names carry 99.9% of the 13F book.

Concentration is the story. INTC + CRWV alone = 71.5% of the portfolio. Rationale synthesized from Nvidia's announced strategic partnerships and disclosed cost bases.

01

Intel Corp

NASDAQ: INTC · 51.6% of book
Market Value
$9,482M
Shares
214.78M
Cost Basis
$23.28/sh
Unrealized Gain
+$4.48B
Announced Sep 2025, $5B common-stock investment at $23.28/share tied to a joint custom-silicon partnership (data-center + client PC). Position moved into the 13F Q4 2025 as the largest single stake. Nvidia's largest-ever public-equity check.
02

CoreWeave Inc

NASDAQ: CRWV · 19.9% of book
Market Value
$3,657M
Shares
47.21M
Q1 Add Price
$87.20/sh
Stake %
~13% of CRWV
Doubled the position in Q1 2026 (+22.94M sh @ $87.20 = ~$2B additional) as part of a January 2026 deal expanding a $6.3B unsold-capacity backstop that runs through April 2032. Originally a $100M seed check in 2023.
03

Synopsys Inc

NASDAQ: SNPS · 10.4% of book
Market Value
$1,911M
Shares
4.82M
Cost Basis
$414.79/sh
Unrealized
−$89M
$2B stake taken in December 2025 after SNPS collapsed on a disappointing Q3 print. Tied to EDA / chip-design workflow integration (Ansys Angstrom + Nvidia CUDA-Q). The only underwater core holding as of Q0.
04

Coherent Corp

NYSE: COHR · 10.4% of book
Market Value
$1,911M
Shares
7.80M
Position Age
1 quarter
Trailing 12M
+350%
New Q1 2026 position, ~$2B, supporting COHR's optical-transceiver capacity build for AI data-center interconnect (400G/800G/1.6T). The only one of Nvidia's three $2B Q1 semis bets (Coherent, Marvell, Lumentum) that showed up on the 13F.
05

Nokia Oyj

NYSE: NOK · 7.3% of book
Market Value
$1,341M
Shares
166.39M
Cost Basis
~$6.20/sh
Unrealized
+$310M
$1B stake announced October 2025 to co-develop AI-RAN (radio access network) reference designs on Nvidia Grace + BlueField. Nvidia's push into a telecom-infra silicon socket previously ceded to Marvell & Broadcom.
06

Nebius Group NV

NASDAQ: NBIS · 0.7% of book
Market Value
$124M
Shares (13F)
1.19M
Off-13F Warrants
+$2.0B
Legacy
ex-YNDX
Common-stock stake ($124M) understates true exposure. Nvidia bought $2B of pre-funded warrants in March 2026 — same economics as common but disclosed under "structured instruments," so they don't populate the 13F until exercised. See callout.
Section 03 & 04 · Latest-Quarter Trades

What NVIDIA bought and dumped this quarter.

Adds show new positions and any >25% additions to existing holdings. Exits show peak share count and last reported value, flagging any position held under four quarters.

Section 03 · Adds

New positions & >25% additions

Q1 2026 (period ending 3/31/26)
Coherent Corp $1,911M
New 7.80M shares initiated · ~$2B strategic investment supporting optical-networking capacity expansion for AI clusters. Position went from $0 → 10.4% of book in one quarter.
Generate Biomedicines $10.4M
New 833K shares · small biotech probe (lead asset GB-0895 for severe asthma). Mirrors Nvidia's now-exited Recursion bet — testing another AI-first drug-discovery platform.
CoreWeave Inc +$1,918M
Added +94% Shares increased 24.28M → 47.21M via $2B Class-A block at $87.20/sh (announced Jan 2026). Underlying dollar exposure rose +110% on stock appreciation.
Intel Corp +$1,557M
Hold, mark-to-market Share count unchanged (214.78M). Position value grew +19.6% on INTC price appreciation from $36.90 → $44.14 during Q1 2026.
Section 04 · Exits

Positions closed & short-tenure flags

Sold-out between Q3 '25 → Q4 '25 (last exit quarter before Q0)
Applied Digital Corp Peak $177M · Last $177M
Peak share count 7.72M @ 9/30/25. Full exit in Q4 2025 despite APLD gaining momentum on hyperscaler lease news. Signals Nvidia's neocloud picks are narrowing to CoreWeave + Nebius.
Arm Holdings plc Peak $192M · Last $192M
Peak 1.1M sh @ 9/30/25 (previously trimmed from a legacy stake). Complete exit despite Nvidia-Meta pact expanding Arm CPU use in data centers. Effectively ends Nvidia's 2020-vintage Arm ownership relationship.
Recursion Pharmaceuticals Peak $62M · Last $37M
Held ~5 quarters; peak Q2 '25. Lost roughly half of value over the life of the position. Replaced thematically by the new Generate Biomedicines probe.
WeRide Inc Peak $18M · Last $17M <4Q hold
Held Q4 '24 → Q3 '25 (four quarters, borderline). China-listed autonomous-driving stake exited with de minimis P&L. First 13F-visible signal that Nvidia's Chinese-tech exposure is being wound down.
Section 05 · Portfolio Themes

Five theses — one supply chain.

Every 13F position (and every off-13F structured deal) maps to a layer of the AI infrastructure stack Nvidia is trying to accelerate or secure. This isn't a diversified book — it's a strategic-financing balance sheet.

Theme 01 · Silicon Alliances

Owning the CPU + EDA layer

$11.39B · 62.0% of book
Custom silicon + design tools = the layers directly upstream of Nvidia's GPU. Locking in Intel foundry partnership and Synopsys chip-design workflow is capacity insurance, not diversification.
  • Intel Corp $9,482M
  • Synopsys Inc $1,911M
Theme 02 · Neocloud Backstop

Financing the GPU renters

$3.78B · 20.6% of book
CoreWeave & Nebius exist to buy Nvidia GPUs and rent capacity. Nvidia both funds them and backstops unsold capacity — the definition of circular financing, from Nvidia's own filings.
  • CoreWeave Inc $3,657M
  • Nebius Group $124M
Theme 03 · Networking & Optical

Interconnect is the new bottleneck

$3.25B · 17.7% of book
Rack-scale AI needs optical + telecom pipes. Coherent for 800G/1.6T optical inside the data center; Nokia for AI-RAN at the edge. Both are hardware-attach plays for future Nvidia BlueField DPUs.
  • Coherent Corp $1,911M
  • Nokia Oyj $1,341M
Theme 04 · AI-Native Biotech

Testing the drug-discovery TAM

$10M · 0.05% of book
Small probe — but a repeat of the pattern. Nvidia held Recursion for ~5 quarters, exited at a loss, then started fresh with Generate Biomedicines. Testing whether AI-first pharma is a repeatable customer.
  • Generate Biomedicines $10M
Theme 05 · Off-13F Structured

The book that dwarfs the 13F

$22.25B · Note 8, 10-K
Non-marketable equity book (private cos + structured instruments) grew 6.6× in FY26. This is where OpenAI, xAI, Groq, Mistral, Wayve, Figure, and the pre-funded-warrant tranches of Nebius/Marvell/Lumentum live. Detailed in the callout below.
  • Balance (Jan 25, 2026) $22,251M
  • Cumul. unrealized gain +$5.3B*
Theme 06 · Exited Cluster

The pruned neocloud + China book

$0 · fully realized Q4 '25
Applied Digital, Arm, Recursion, WeRide — all removed in a single quarter, none announced in advance. Signals a portfolio consolidation: fewer, larger, more strategically-tied bets. The China autonomous-driving thread (WRD) is now closed.
  • Applied Digital Exited $177M
  • Arm Holdings Exited $192M
  • Recursion + WeRide Exited $54M
Section 05b · Off-13F Structured & Private Deals

The shadow portfolio: $22B+ off the 13F.

These positions live in Note 8 of NVDA's FY26 10-K ("Non-marketable Equity Securities") or in structured instruments (pre-funded warrants, commitments) that don't appear on the 13F. Sources: 10-K Note 8 (SEC), 10-Q Q1 FY27 Note 8 (SEC), and Tier-1 outlets (Bloomberg, Reuters, WSJ).

Investee / Deal Instrument Size (Approx) Status & Source
OpenAI
Foundation-model lab
Multi-year strategic commitment Up to $100B Announced Sep 22, 2025 · progressive equity + GPU deployment tied to 10 GW of capacity · WSJ, Reuters
xAI (X.AI Corp)
Foundation-model lab
Series G common / preferred ~$5B Reported Sep 2025 as part of xAI's $20B raise · Bloomberg, FT
Nebius Group
EU neocloud, in addition to $124M common
Pre-funded warrants $2.0B Announced Mar 2026 · same economics as common, off-13F until exercised · 10-Q Note 8
Marvell Technology
Custom AI silicon partner
Structured investment (not disclosed as common) $2.0B Announced Q1 2026 · does not appear in 13F · Company press releases, Reuters
Lumentum Holdings
Optical for AI networking
Structured (undisclosed form) $2.0B Announced Q1 2026 alongside COHR · absent from 13F · Bloomberg
Groq Inc
Inference-silicon startup
Non-exclusive tech license + equity Undisclosed 10-K MD&A specifically cites "execution of a non-exclusive license agreement with Groq" in FY26 investing outflows · 10-K
Infrastructure funds
Equity-method investments
LP interests $1.0B invested Max loss exposure (invested + committed) $2.3B as of Apr 26, 2026 · 10-Q Note 8
Total investment commitments
Aggregate undrawn
Various $27.0B Expected to be deployed through remainder of FY27 · 10-Q Note 8
Long-term lock-up equity
Locked-up positions (likely INTC + others)
Publicly-held w/ transfer restrictions $4.8B Locked through Dec 2027 · classified in Other Assets rather than short-term marketable securities · 10-K Note 3

Reconciliation. The 10-K reports Nvidia's non-marketable equity book at $22.25B as of Jan 25, 2026 (up from $3.39B a year prior). By April 26, 2026, cumulative gross unrealized gains had grown to $5.3B — implying the private portfolio is up meaningfully on a mark-to-model basis even before the OpenAI and structured-warrant tranches fully vest. Nvidia's $27B of undrawn commitments means the shadow book is expected to roughly double again during FY27.

Section 06 · Prompt Restated (for reproducibility)
HTML rpt [NVDA] port.
FETCH:(a)EDGAR CIK sec.gov/cgi-bin/browse-edgar?action=getcompany&company={CO}&type=13F.No13F-HR→say in lede,pivot 10-K/10-Q/8-K equity disc,same shape.(b)5 latest 13F-HR accnos.Rows valuesider.com/guru/{slug}/portfolio/{YYYY}/{Q}?page={N},paginate til all caught.Totals 13f.info/manager/{CIK}-{slug}.NEVER fetch 13f.info detail(JS).NEVER fetch SEC subdocs(dyn URLs blocked).(c)Latest 10-K Note4/5"Inv equity sec":cost/MV/own%/div per name+struct instr(pref/warr/conv).Not in 13F.(d)Σrows/qtr=SEC total±round.Δ→chk 13F-HR/A amend(may reveal confid-treat pos).Footnote recon.(e)Priv/foreign/pre-IPO:xchk press(Nikkei/BBG/Reuters/IR/Fm4/13G/13D).Incl only if in 10-K OR Tier-1 outlet.
TOP:brand strip,hero,1p lede,4 stat cards(13F val,Q/QΔ,non-mkt eq MV,largest stake).
§(ORDER IS FIXED):(1)Full tbl[IMMED AFTER STATS],every pos×5Q:Co|Tkr|Sec|Q-4|Q-3|Q-2|Q-1|Q0($M,$prefix every cell)|Move(Hold/New/Added/Trim/Exited).Totals row=SEC.Incl mid-per exits."—"=pre-hld,"$0"=post-exit.(2)Top hldgs ranked cards:val/sh/cost/rationale.(3&4)Adds+Exits latest Q side-by-side:adds=new+>25% adds;exits=peak sh+last val,flag<4Q hlds.(5)4-6 themes cards:$tot+per-name+1-ln thesis.Off-13F struct deals=sep callout.(6)Restate prompt @base.
STY:bg#FBFAF6 ink#0F0F10 sky#5DCDF1 sage#7DCFB6 honey#FFB36B.H=Recoleta(Fraunces fb),body=Manrope,nums=JBMono tab.Wht cards r12 soft shdw,L color-bar per theme.Pills Hold/New/Added/Trim/Exited.Resp 1col<900px.
Evolve Financial · Portfolio Teardown Series · Numbers Ledger sources: SEC EDGAR (13F-HR accession nos. listed), NVDA 10-K FY26 & 10-Q Q1 FY27, Bloomberg, Reuters, WSJ, Investing.com, Motley Fool, TheStreet, Sherwood News, 13f.info
© 2026 Balaji Bhaskar · Not investment advice · Verify with primary filings before acting